A securities class action has been filed in the USDC — M.D.TN. against Arcadia Healthcare Company, Inc. (ACHC) (“Arcadia Healthcare” “Arcadia” or the “Company”), on behalf of all those that purchased or otherwise acquired Arcadia securities between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”).
Defendant Acadia Healthcare describes itself as follows: Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2023, Acadia operated a network of 253 behavioral healthcare facilities with approximately 11,100 beds in 39 states and Puerto Rico. With approximately 23,000 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.
The complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that:
(1) Acadia Healthcare’s business model centered on holding vulnerable people against their will in its facilities, including in cases where it was not medically necessary to do so;
(2) while in Acadia Healthcare facilities, many patients were subjected to abuse;
(3) Acadia Healthcare deceived insurance providers into paying for patients to stay in its facilities when it was not medically necessary; and
(4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times, thereby harming investors.
If you purchased Arcadia securities during the class period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.
About Lowey Dannenberg
Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.